BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9583802)

  • 1. HLA class II region sequences, 1998.
    Marsh SG
    Tissue Antigens; 1998 Apr; 51(4 Pt 2):467-507. PubMed ID: 9583802
    [No Abstract]   [Full Text] [Related]  

  • 2. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families.
    Carrington M; Stephens JC; Klitz W; Begovich AB; Erlich HA; Mann D
    Hum Immunol; 1994 Nov; 41(3):234-40. PubMed ID: 7868379
    [No Abstract]   [Full Text] [Related]  

  • 3. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
    Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
    Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular organization of the class II genes of the human and mouse major histocompatibility complexes.
    Carson S; Trowsdale J
    Oxf Surv Eukaryot Genes; 1986; 3():63-94. PubMed ID: 2855304
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility to alloimmunization to platelet HPA-1a antigen involves TAP1 polymorphism.
    Braud V; Chevrier D; Cesbron A; Bignon JD; Kaplan C; Valentin N; Muller JY
    Hum Immunol; 1994 Oct; 41(2):141-5. PubMed ID: 7860359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region.
    Bahram S; Arnold D; Bresnahan M; Strominger JL; Spies T
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10094-8. PubMed ID: 1946428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population.
    Alvarado-Guerri R; Cabrera CM; Garrido F; López-Nevot MA
    Hum Immunol; 2005 Aug; 66(8):921-30. PubMed ID: 16216677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombination in the HLA class II region.
    Cullen M; Noble J; Erlich H; Thorpe K; Beck S; Klitz W; Trowsdale J; Carrington M
    Am J Hum Genet; 1997 Feb; 60(2):397-407. PubMed ID: 9012413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis.
    Kuwata S; Yanagisawa M; Saeki H; Nakagawa H; Etoh T; Tokunaga K; Juji T; Shibata Y
    J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 2):1051-60. PubMed ID: 8543762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of TAP and HLA-DM polymorphism in thai rheumatoid arthritis.
    Vejbaesya S; Luangtrakool P; Luangtrakool K; Sermduangprateep C; Parivisutt L
    Hum Immunol; 2000 Mar; 61(3):309-13. PubMed ID: 10689121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic organization of the ovine MHC class II region.
    Scott PC; Choi CL; Brandon MR
    Immunogenetics; 1987; 25(2):116-22. PubMed ID: 3028945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
    Eiermann TH; Martin A; Wölpl A; Goldmann SF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
    [No Abstract]   [Full Text] [Related]  

  • 13. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis.
    Paul C; Haas JP; Schoenwald U; Truckenbrodt H; Bettinotti MP; Bönisch J; Brünnler G; Keller E; Nevinny-Stickel C; Yao Z
    Immunogenetics; 1994; 39(1):61-4. PubMed ID: 8225439
    [No Abstract]   [Full Text] [Related]  

  • 15. TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantation.
    Kobayashi T; Yokoyama I; Hayashi S; Negita M; Namil Y; Katayama A; Nagasaka T; Koike C; Tachi Y; Mei GL; Haba T; Tominaga Y; Naruse T; Inoko H; Uchida K; Takagi H
    Transplant Proc; 1998 Feb; 30(1):29-30. PubMed ID: 9474948
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis.
    Fakler JW; Schmitt-Egenolf M; Vejbaesya S; Boehncke WH; Sterry W; Eiermann TH
    Hum Immunol; 1994 Aug; 40(4):299-302. PubMed ID: 8002377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQ and TAP2 genes in patients with insulin-dependent diabetes mellitus.
    Lotfi M; Sastry A; Ye M; VanderMeulen J; Dosch HM; Singal DP
    Immunol Lett; 1994 Jul; 41(2-3):201-4. PubMed ID: 8002038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
    Todd JA; Bell JI; McDevitt HO
    Nature; 1987 Oct 15-21; 329(6140):599-604. PubMed ID: 3309680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis.
    Moins-Teisserenc H; Semana G; Alizadeh M; Loiseau P; Bobrynina V; Deschamps I; Edan G; Birebent B; Genetet B; Sabouraud O
    Hum Immunol; 1995 Mar; 42(3):195-202. PubMed ID: 7759306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organization of the chromosomic region of the major human histocompatibility complex].
    Vernet C; Sidibé I; Pontarotti P
    Pathol Biol (Paris); 1992 Oct; 40(8):822-30. PubMed ID: 1484743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.